The U.S. Food and Drug Administration (FDA) on Wednesday approved updated Risk Evaluation and Mitigation Strategy (REMS) labeling for Travere Therapeutics, Inc.’s (NASDAQ:TVTX) Filspari (sparsentan), ...

Currently, kidney transplantation is the most effective treatment to ensure survival and improve the quality of life of patients with end-stage chronic kidney disease, and it is widely practiced in ...

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Sanskruti Lakhotia from RMIT's Sir Ian Potter NanoBioSensing Facility holds a bottle of the nanoparticle formula being used to develop Nexsen's kidney diagnostic tests. A simple blood test could ...

SensTech, one of Cornell’s newest project teams, received a third-place award at the international biosensor competition, SensUs, for its wearable biosensor designed to manage kidney disease this ...

Kidney failure is often seen as a permanent condition, but the reality is more nuanced. In some cases, kidney function can improve or stabilise, especially when the problem is detected early and ...

Childhood cancer survivors have a significantly higher risk of CKD and hypertension, often appearing within the first year post-treatment. Current guidelines for monitoring kidney health in childhood ...

A new study found that people with systemic lupus erythematosus (SLE) may face a significantly higher risk of developing ...

A wearable health monitor can reliably measure levels of important biochemicals in sweat during physical exercise. The 3D-printed monitor could someday provide a simple and non-invasive way to track ...

Dialysis or a kidney transplant is needed for kidney failure to help you live longer. Early symptoms like fatigue and nausea ...